Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.32B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$975M |
| 3 |
AABA
Altaba Inc
AABA
|
+$871M |
| 4 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$372M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.02B |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$860M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.12% |
| 2 | Healthcare | 4.92% |
| 3 | Financials | 4.07% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4826
DB Gold Double Long ETN due February 15, 2038
DGP
$253M
| $102K | ﹤0.01% |
4,447
| – | – |
|
|
ESPR
4827
CALL
DELISTED
Esperion Therapeutics
ESPR
| $102K | ﹤0.01% |
2,200
-400
| -15% | -$14.7K |
|
4828
Ultragenyx Pharmaceutical
RARE
$2.64B
| $102K | ﹤0.01% |
1,642
-21,943
| -93% | -$1.32M |
|
4829
TechTarget
TTGT
$282M
| $102K | ﹤0.01% |
9,815
-58
| -0.6% | -$546 |
|
4830
CALL
Wendy's
WEN
$1.39B
| $102K | ﹤0.01% |
6,600
+4,000
| +154% | +$60.6K |
|
|
GSV
4831
DELISTED
Gold Standard Ventures Corp.
GSV
| $102K | ﹤0.01% |
+59,750
| New | +$107K |
|
|
LDR
4832
DELISTED
Landauer Inc
LDR
| $102K | ﹤0.01% |
1,947
+249
| +15% | +$12.8K |
|
4833
ICL Group
ICL
$6.89B
| $101K | ﹤0.01% |
21,420
+11,807
| +123% | +$50.9K |
|
4834
IDT Corp
IDT
$1.61B
| $101K | ﹤0.01% |
8,301
-5,344
| -39% | -$69.3K |
|
|
BRSL
4835
CALL
Brightstar Lottery PLC
BRSL
$2.02B
| $101K | ﹤0.01% |
5,500
+1,600
| +41% | +$32.7K |
|
4836
CALL
NiSource
NI
$20B
| $101K | ﹤0.01% |
4,000
-500
| -11% | -$12.5K |
|
4837
Invesco Semiconductors ETF
PSI
$2.43B
| $101K | ﹤0.01% |
7,260
| – | – |
|
4838
Metallus
MTUS
$900M
| $101K | ﹤0.01% |
6,616
-23,286
| -78% | -$345K |
|
|
CUTR
4839
CALL
DELISTED
Cutera, Inc.
CUTR
| $101K | ﹤0.01% |
+3,900
| New | +$85.1K |
|
|
USAK
4840
DELISTED
USA Truck Inc
USAK
| $101K | ﹤0.01% |
11,649
-10,011
| -46% | -$68.7K |
|
|
DYNC
4841
DELISTED
Vistra Energy Corp.
DYNC
| $101K | ﹤0.01% |
1,671
| – | – |
|
|
SCMP
4842
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $101K | ﹤0.01% |
9,580
-12,102
| -56% | -$123K |
|
|
RELY
4843
DELISTED
Real Industry, Inc.
RELY
| $101K | ﹤0.01% |
34,658
+17,873
| +106% | +$48.7K |
|
|
MNR
4844
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $101K | ﹤0.01% |
6,669
+2,992
| +81% | +$44.2K |
|
4845
PUT
Conagra Brands
CAG
$7.07B
| $100K | ﹤0.01% |
2,800
-200
| -7% | -$7.75K |
|
4846
Lennar Class B
LEN.B
$20.2B
| $100K | ﹤0.01% |
2,389
+1,242
| +108% | +$50.3K |
|
4847
PUT
Xylem
XYL
$28.3B
| $100K | ﹤0.01% |
1,800
-2,400
| -57% | -$125K |
|
|
CNR
4848
PUT
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $100K | ﹤0.01% |
+6,000
| New | +$102K |
|
|
ERN
4849
DELISTED
Erin Energy Corp
ERN
| $100K | ﹤0.01% |
69,304
+6,359
| +10% | +$11.7K |
|
4850
PUT
Aegon
AEG
$14B
| $99K | ﹤0.01% |
24,518
+23,218
| +1,786% | +$90.9K |
|
Similar funds
Barclays's Q2 2017 Portfolio in Review
As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
- Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
- Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
- Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
- Barclays opened 436 new positions and closed 395 in Q2 2017.
- Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.
Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.